A cut-off of 1.77 ng of C4a /mg plasma protein represented an appropriate value to distinguish cirrhotic patients from HCC patients, with a sensitivity of 63% and a specificity of 65%. This evidence concerns the gene C4A and hepatocellular carcinoma.